1. Home
  2. RGEN vs GMED Comparison

RGEN vs GMED Comparison

Compare RGEN & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • GMED
  • Stock Information
  • Founded
  • RGEN 1981
  • GMED 2003
  • Country
  • RGEN United States
  • GMED United States
  • Employees
  • RGEN N/A
  • GMED N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • GMED Medical/Dental Instruments
  • Sector
  • RGEN Health Care
  • GMED Health Care
  • Exchange
  • RGEN Nasdaq
  • GMED Nasdaq
  • Market Cap
  • RGEN 7.6B
  • GMED 11.6B
  • IPO Year
  • RGEN N/A
  • GMED 2012
  • Fundamental
  • Price
  • RGEN $156.55
  • GMED $88.11
  • Analyst Decision
  • RGEN Buy
  • GMED Buy
  • Analyst Count
  • RGEN 12
  • GMED 13
  • Target Price
  • RGEN $187.44
  • GMED $95.42
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • GMED 1.0M
  • Earning Date
  • RGEN 02-19-2025
  • GMED 02-20-2025
  • Dividend Yield
  • RGEN N/A
  • GMED N/A
  • EPS Growth
  • RGEN N/A
  • GMED N/A
  • EPS
  • RGEN N/A
  • GMED 0.67
  • Revenue
  • RGEN $633,513,000.00
  • GMED $2,478,596,000.00
  • Revenue This Year
  • RGEN $2.28
  • GMED $62.39
  • Revenue Next Year
  • RGEN $9.88
  • GMED $6.71
  • P/E Ratio
  • RGEN N/A
  • GMED $131.18
  • Revenue Growth
  • RGEN N/A
  • GMED 102.10
  • 52 Week Low
  • RGEN $113.50
  • GMED $49.33
  • 52 Week High
  • RGEN $211.13
  • GMED $90.48
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • GMED 69.74
  • Support Level
  • RGEN $149.15
  • GMED $86.28
  • Resistance Level
  • RGEN $160.64
  • GMED $90.48
  • Average True Range (ATR)
  • RGEN 5.96
  • GMED 1.86
  • MACD
  • RGEN 0.91
  • GMED 0.46
  • Stochastic Oscillator
  • RGEN 79.57
  • GMED 73.98

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Share on Social Networks: